January 15, 2009 / 10:28 AM / 11 years ago

Ranbaxy CEO: Mulling buying FDA-approved facilities

(Corrects alert to say ... facilities ..., not ... U.S. facilities)

TOKYO, Jan 15 (Reuters) - Ranbaxy Laboratories RANB.BO CEO Malvinder Mohan Singh said his firm was considering acquiring manufacturing facilities that already have approval from the U.S. Food and Drug Administration (FDA). (Reporting by Yumiko Nishitani)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below